For example, patients are often treated with endocrine therapy or combined chemotherapy when the tumor is estrogen receptor/progesterone receptor (ER/PR)‐positive or treated with human epidermal growth factor receptor 2‐(HER2) targeted drugs (trastuzumab or pertuzumab) or concurrent chemotherapy when the tumor is HER2 positive. This evidence concerns the gene PGR and neoplasm.